
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
Emmanuel Papadakis Maintained (BNTX) at Hold and Held Target at $200 on, Apr 1st, 2022


🞛 This publication is a summary or evaluation of another publication
Emmanuel Papadakis of Deutsche Bank, Maintained "BioNTech SE" (BNTX) at Hold and Held Target at $200 on, Apr 1st, 2022.
Emmanuel has made no other calls on BNTX in the last 4 months.
There are 3 other peers that have a rating on BNTX. Out of the 3 peers that are also analyzing BNTX, 2 agree with Emmanuel's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Simon Baker of "Redburn Partners" Upgraded from Strong Sell to Hold on, Tuesday, February 1st, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $217 on, Tuesday, February 1st, 2022
This is the rating of the analyst that currently disagrees with Emmanuel
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $339 on, Wednesday, February 23rd, 2022